Soliris 300 mg Injection

Description

Uses of Soliris 300 mg Injection

Soliris contains eculizumab. It is a monoclonal antibody. Soliris 300 mg is commonly prescribed for the treatment of:

• Paroxysmal Nocturnal Hemoglobinuria (PNH)- It is a rare and life-threatening blood disease.
• Generalized Myasthenia Gravis (gMG)- Common in anti-AChR antibody-positive adults.
• Atypical Hemolytic Uremic Syndrome (aHUS)- This condition leads to abnormal blood clotting.
• Neuromyelitis Optica Spectrum Disorder (NMOSD)- Common in adults who are anti-AQP4 antibody-positive.

Dosage of Soliris 300 mg Injection

• It is an IV treatment. Hence, only an expert healthcare professional will administer the injection. Do not self-administer.
• Doctors recommend weekly infusion for the first couple of weeks.
• After that, a maintenance dose will be recommended every 2 weeks.

Precautions and Warnings

• Patients must get a meningococcal vaccine two weeks before starting the Soliris 300 mg injection.
• Some common side effects of the injection are headache, nausea, fatigue, etc. These mostly don’t require medical attention and disappear on their own.
• Serious side effects include infusion reactions, life-threatening meningococcal infections, and hemolysis if the patient suddenly stops taking the treatment.
• Pregnant women and lactating mothers must consult their doctors before taking the injection.

Why choose SDO for medicine supply and export?

SDO Pharmed is a leading UAE-based manufacturer and supplier of Soliris 300 mg Injection. It is a reputed UAE-based medicine supply and export company. The company also exports a variety of other medicines like cancer treatments, vaccines, and general pharmaceutical products. SDO is known for its commitment to maintaining quality and reliability. We deliver the best quality medicines to international clients like Saudi Arabia, Yemen, Kazakhstan, Oman, Russia, and most European countries. We ensure the timely delivery of premium-quality medicines worldwide.